Salivary gland atresia
Salivary gland atresia is a rare congenital condition characterized by the absence or underdevelopment of one or more of the salivary glands. This condition can affect any of the major salivary glands, including the parotid gland, the submandibular gland, and the sublingual gland.
Etiology[edit | edit source]
The exact cause of salivary gland atresia is unknown. However, it is believed to be due to a disruption in the normal development of the salivary glands during the embryonic stage. Some researchers suggest that it may be associated with genetic factors or environmental influences during pregnancy.
Clinical Presentation[edit | edit source]
Individuals with salivary gland atresia may present with a variety of symptoms depending on the severity of the condition and the specific glands affected. Common symptoms include dry mouth (xerostomia), difficulty swallowing (dysphagia), and recurrent oral infections. In severe cases, the condition can lead to nutritional deficiencies and growth retardation.
Diagnosis[edit | edit source]
Diagnosis of salivary gland atresia is typically made through a combination of physical examination, medical history, and imaging studies. Ultrasound, computed tomography (CT) scan, and magnetic resonance imaging (MRI) can be used to visualize the salivary glands and assess their size and structure.
Treatment[edit | edit source]
Treatment for salivary gland atresia is primarily supportive and aims to manage the symptoms. This may include the use of artificial saliva products, good oral hygiene practices, and regular dental check-ups. In some cases, surgical intervention may be necessary.
Prognosis[edit | edit source]
The prognosis for individuals with salivary gland atresia varies depending on the severity of the condition and the specific glands affected. With appropriate management, most individuals can lead a normal life. However, they may require ongoing care to manage their symptoms and prevent complications.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD